Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9434905 | 0.81 | BRD4 (0.43) | BRD4BRD2PIK3CDLMNACA12 | |
| SCHEMBL6047009 | 0.78 | — | — | |
| SCHEMBL6645160 | 0.78 | BRD4 (0.40) | BRD4BRD2PIK3CDLMNACA12 | |
| SCHEMBL20243443 | 0.75 | BRD4 (0.38) | BRD4BRD2PIK3CDLMNACA12 | |
| SCHEMBL26805306 | 0.72 | PIK3CD (0.44) | BRD4BRD2PIK3CDLMNACA12 | |
| SCHEMBL22635867 | 0.71 | BRD4 (0.41) | BRD4BRD2PIK3CDLMNATSHR | |
| SCHEMBL9634467 | 0.71 | BRD4 (0.41) | BRD4BRD2PIK3CDLMNACA12 | |
| SCHEMBL7029657 | 0.70 | BRD4 (0.39) | BRD4BRD2PIK3CDALDH1A1 | |
| SCHEMBL6046209 | 0.69 | — | — | |
| SCHEMBL5230712 | 0.68 | BRD4 (0.35) | BRD4BRD2PIK3CDLMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975340-B2 | Active agent-containing fibrous structure articles | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-13 | — | — | US | disclosed |
| US-20190111404-A9 | Substrates, Systems, and Methods for Array Synthesis and Biomolecular Analysis | VIBRANT HOLDINGS, LLC | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975340-B2 | Active agent-containing fibrous structure articles | MMP1, FIBP, MMP8 | BRD4 3037/4885BRD2 3290/4885PIK3CD 3805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.